Literature DB >> 16340243

Therapeutic options in advanced laryngeal cancer: an overview.

Fernando L Dias1, Roberto A Lima, Jacob Kligerman, Claudio R Cernea.   

Abstract

Historically, patients with advanced laryngeal cancer have been treated with radical surgery and adjuvant radiation therapy. Intensive surgical research has allowed surgeons to deal with almost any local extension and to propose an appropriate surgical procedure for each case. Several function-sparing surgical options are available to treat moderately advanced/advanced laryngeal cancer. Better understanding of the anatomy and biology of cancer in this anatomical site has enabled us to devise effective oncological strategies associated with a great effort to preserve laryngeal function. Numerous efforts have been made to augment the therapeutic armamentarium with the addition of chemotherapeutic agents combined with radiation therapy. For advanced laryngeal cancer, the debate is still open between partial/subtotal surgical procedures, which are more efficient but sacrifice parts of the larynx, and radiotherapy/chemoradiation protocols which can preserve the larynx and its function even though it requires radical surgery for salvage. Efforts should be made to select patients properly, in an individual basis, based on tumor characteristics, clinical aspects, patient's expectations, and the expertise of the head and neck oncologic team for the various therapeutic strategies in order to get better oncological results in association with the preservation of the laryngeal form and function, when possible.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16340243     DOI: 10.1159/000090040

Source DB:  PubMed          Journal:  ORL J Otorhinolaryngol Relat Spec        ISSN: 0301-1569            Impact factor:   1.538


  5 in total

1.  Organ preservation vs primary surgery in the management of T3 laryngeal and hypopharyngeal cancers.

Authors:  Sudhir Vasudevan Nair; Manish Mair; Noopur Sawarkar; Swagnik Chakrabarti; Burhanuddin Qayyumi; Deepa Nair; Pankaj Chaturvedi; Tejpal Gupta; Jai Prakash Agrawal
Journal:  Eur Arch Otorhinolaryngol       Date:  2018-06-29       Impact factor: 2.503

2.  CCNY Accelerates Cylcin E Expression to Regulate the Proliferation of Laryngeal Carcinoma Cells via MEK/ERK Signaling Pathway.

Authors:  Xiaoting Zhao; Mei Jiang; Ziyu Wang; Xiaohong Chen; Hongzhen Wang; Wentao Yue; Chao Cai
Journal:  Cancer Manag Res       Date:  2020-06-23       Impact factor: 3.989

3.  Supratracheal laryngectomy: a multi-institutional study.

Authors:  Ariana M Garcia; Fernando L Dias; Antônio J Gonçalves; Claudio R Cernea; Emilson Q Freitas; Marcelo B Menezes; Marco Aurélio V Kulcsar
Journal:  Braz J Otorhinolaryngol       Date:  2019-05-23

4.  Preservation of laryngeal function improves outcomes of patients with hypopharyngeal carcinoma.

Authors:  Tong Jin; Xuezhong Li; Dapeng Lei; Dayu Liu; Qiuan Yang; Guojun Li; Xinliang Pan
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-10       Impact factor: 2.503

5.  Failure of pedicled flap reconstruction in the head and neck area: A case report of a bilateral subclavian artery stenosis.

Authors:  Matti Sievert; Michael Koch; Konstantinos Mantsopoulos; Maximilian Traxdorf; Sarina K Mueller; Heinrich Iro; Claudia Scherl
Journal:  Int J Surg Case Rep       Date:  2020-10-12
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.